NUZ 0.00% 20.0¢ neurizon therapeutics limited

3 years perfecting a new class of drug and treatment to perfect...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,433 Posts.
    lightbulb Created with Sketch. 1513
    3 years perfecting a new class of drug and treatment to perfect its its efficacy, safety and test its shelf life chemical stability is nothing, especially when one is operating at the very bleeding edge of human knowledge as is the case regarding MPL's effect on the mTOR system (let alone eyerything else in the body of the patient)..

    The average length of time to develop a new drug is 11 years. They're 7 years into it, and that includes a setback of 3 years due to the capsules back in 2016/17 and they're in phase IIb dog trials and ready to go this year with the first phase II human trials (MND0 And note, phase II must be done with the drug that they intend to commercialise..

    Either you're an ignoramous concerning biotech R&D matters or you're a fake with your "concerns". Please choose.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $97.32M
Open High Low Value Volume
20.5¢ 20.5¢ 20.0¢ $56.77K 280.8K

Buyers (Bids)

No. Vol. Price($)
10 401728 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 52780 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.